Brawn Biotech Ltd — Important, 02-09-2025: Company Update

Brawn Biotech's Board has approved several key updates. The company will alter its Memorandum of Association to align with current corporate laws, clarifying its object clauses without changing the main business focus. Shareholders will need to approve this. The Board also approved convening the 40th Annual General Meeting via video conference. Additionally, Mr. Amit Kumar's re-appointment as Manager for another five years, effective from February 12, 2026, was approved, pending shareholder consent. The Board's Report for the year ended March 31, 2025, was also considered and approved.